| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |